Akums Drugs and Pharmaceutical Cash Flow Reinvestment Rate
Akums Drugs and Pharmaceutical cash flow reinvestment rate. Akums Drugs and Pharmaceutical (AKUMS) has a Cash Flow Reinvestment Rate of 0.10x as of September 2025, reinvesting Rs1.12 Billion (capex Rs1.12 Billion ) from operating cash flow of Rs11.52 Billion. Explore debt repayment capacity of Akums Drugs and Pharmaceutical to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Akums Drugs and Pharmaceutical (2022–2026)
Cash flow reinvestment rate of Akums Drugs and Pharmaceutical from 2022 to 2026. Historical reinvestment intensity for Akums Drugs and Pharmaceutical across 5 annual periods. Explore reinvestment intensity of Akums Drugs and Pharmaceutical to see what proportion of operating cash flow is directed to capital expenditures.
Akums Drugs and Pharmaceutical Cash Flow Reinvestment Rate by Year (2022–2026)
Akums Drugs and Pharmaceutical cash flow reinvestment rate by year from 2022 to 2026. Year-by-year capital reinvestment analysis for Akums Drugs and Pharmaceutical. For the full cash flow conversion analysis, see AKUMS cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.81x | Rs9.77 Billion | Rs12.11 Billion | Rs2.31 Billion | ▼ -54.2% |
| 2025 | 1.76x | Rs8.20 Billion | Rs4.65 Billion | Rs2.72 Billion | ▲ +36.9% |
| 2024 | 1.29x | Rs6.42 Billion | Rs4.98 Billion | Rs3.11 Billion | ▼ -64.1% |
| 2023 | 3.59x | Rs6.33 Billion | Rs1.77 Billion | Rs3.29 Billion | ▼ -76.8% |
| 2022 | 15.46x | Rs4.92 Billion | Rs318.54 Million | Rs2.58 Billion | — |